Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein D2 pseudogene 1 (SNRPD2P1), also known as bA478K7.1, is a pseudogene; it is a nonfunctional segment of DNA that resembles the functional small nuclear ribonucleoprotein D2 (SNRPD2) gene but does not encode a functional protein product[1][5]. Pseudogenes are typically the result of duplication or retrotransposition events and have lost their protein-coding or regulatory functions[5]. Therefore, SNRPD2P1 is not a functional gene, is not a therapeutic target or receptor, and does not participate in biological pathways or disease mechanisms. All information relevant to functional splicing proteins or disease is associated with the parent gene SNRPD2, not the SNRPD2P1 pseudogene[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein D2 pseudogene 1 (SNRPD2P1).